GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (NAS:OPK) » Definitions » Piotroski F-Score

OPKO Health (OPKO Health) Piotroski F-Score

: 3 (As of Today)
View and export this data going back to 1995. Start your Free Trial

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

OPKO Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for OPKO Health's Piotroski F-Score or its related term are showing as below:

OPK' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 8
Current: 3

During the past 13 years, the highest Piotroski F-Score of OPKO Health was 8. The lowest was 1. And the median was 4.


OPKO Health Piotroski F-Score Historical Data

The historical data trend for OPKO Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OPKO Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 8.00 5.00 1.00 3.00

OPKO Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 2.00 2.00 4.00 3.00

Competitive Comparison

For the Diagnostics & Research subindustry, OPKO Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health Piotroski F-Score Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where OPKO Health's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -18.267 + -19.64 + -84.473 + -66.483 = $-188.9 Mil.
Cash Flow from Operations was -22.647 + -0.365 + 33.109 + -38.294 = $-28.2 Mil.
Revenue was 237.577 + 265.418 + 178.595 + 181.904 = $863.5 Mil.
Gross Profit was 99.263 + 126.479 + 47.677 + 44.707 = $318.1 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(2167.259 + 2169.67 + 2158.899 + 2056.68 + 2011.698) / 5 = $2112.8412 Mil.
Total Assets at the begining of this year (Dec22) was $2,167.3 Mil.
Long-Term Debt & Capital Lease Obligation was $283.4 Mil.
Total Current Assets was $309.5 Mil.
Total Current Liabilities was $200.1 Mil.
Net Income was -55.433 + -101.65 + -86.091 + -85.231 = $-328.4 Mil.

Revenue was 329.219 + 309.893 + 179.744 + 185.34 = $1,004.2 Mil.
Gross Profit was 85.344 + 115.582 + 31.299 + 55.994 = $288.2 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(2399.715 + 2306.858 + 2369.602 + 2224.785 + 2167.259) / 5 = $2293.6438 Mil.
Total Assets at the begining of last year (Dec21) was $2,399.7 Mil.
Long-Term Debt & Capital Lease Obligation was $254.5 Mil.
Total Current Assets was $394.5 Mil.
Total Current Liabilities was $213.5 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

OPKO Health's current Net Income (TTM) was -188.9. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

OPKO Health's current Cash Flow from Operations (TTM) was -28.2. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-188.863/2167.259
=-0.08714371

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-328.405/2399.715
=-0.13685167

OPKO Health's return on assets of this year was -0.08714371. OPKO Health's return on assets of last year was -0.13685167. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

OPKO Health's current Net Income (TTM) was -188.9. OPKO Health's current Cash Flow from Operations (TTM) was -28.2. ==> -28.2 > -188.9 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=283.448/2112.8412
=0.1341549

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=254.521/2293.6438
=0.11096797

OPKO Health's gearing of this year was 0.1341549. OPKO Health's gearing of last year was 0.11096797. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=309.476/200.052
=1.54697779

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=394.525/213.48
=1.84806539

OPKO Health's current ratio of this year was 1.54697779. OPKO Health's current ratio of last year was 1.84806539. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

OPKO Health's number of shares in issue this year was 751.914. OPKO Health's number of shares in issue last year was 751.878. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=318.126/863.494
=0.36841715

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=288.219/1004.196
=0.28701469

OPKO Health's gross margin of this year was 0.36841715. OPKO Health's gross margin of last year was 0.28701469. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=863.494/2167.259
=0.39842677

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=1004.196/2399.715
=0.41846469

OPKO Health's asset turnover of this year was 0.39842677. OPKO Health's asset turnover of last year was 0.41846469. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+1+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

OPKO Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

OPKO Health  (NAS:OPK) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


OPKO Health Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of OPKO Health's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


OPKO Health (OPKO Health) Business Description

Traded in Other Exchanges
Address
4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.
Executives
Frost Phillip Md Et Al 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Hsiao Jane Ph D director 4400 BISCAYNE BLVD, MIAMI FL 33137
Gary J. Nabel director, officer: Chief Innovation Officer C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Elias A. Zerhouni director, officer: Vice Chairman and President 2099 PENNSYLVANIA AVENUE, NW 12TH FLOOR, WASHINGTON DC 20006
John A Paganelli director, other: Chairman of the Board OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Steven D Rubin director OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Pfenniger Richard C Jr director 4400 BISCAYNE BLVD., MIAMI FL 33137
Alexis Borisy director C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 16TH FLOOR, CAMBRIDGE MA 02142
Jon R Cohen director, officer: SVP OPKO; Exec Chairman BRLI C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Prem A Lachman director 4400 BISCAYNE BLVD., MIAMI FL 33137
Roger Md Medel director 1301 CONCORD TERRACE, SUNRISE FL 33323
Rulfo Fernando Hernandez officer: CAO, Treasurer C/O OPKO HEALTH INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Anthony J Japour director 19805 N. CREEK PARKWAY, BOTHELL WA 98011
Robert Scott Fishel director C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Adam Logal officer: Exec.Dir .of Fin., CAO,Treas. OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137